NCT06692452 2026-01-07
Tazemetostat Plus CHOP in 1L T-cell Lymphoma
Dana-Farber Cancer Institute
Phase 2 Suspended
Dana-Farber Cancer Institute
Henan Cancer Hospital
Fondazione Italiana Linfomi - ETS
N.N. Petrov National Medical Research Center of Oncology
Acrotech Biopharma Inc.
Chipscreen Biosciences, Ltd.